Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 555

1.

Percutaneous pulmonary debanding for an infant complicated by spontaneously closing muscular ventricular septal defect: A case report and in vitro study.

Terazawa A, Fujii T, Sasaki T, Asada D, Tarui S, Miyahara Y, Ishino K, Soga T, Tomita H.

J Cardiol Cases. 2017 Nov 6;17(1):16-20. doi: 10.1016/j.jccase.2017.08.012. eCollection 2018 Jan.

2.

Static balloon atrial septostomy for the purpose of left heart intervention in postoperative adult CHD.

Fujii T, Tomita H, Hata Y, Sasaki T, Asada D, Tarui S, Miyahara Y, Ishino K, Soga T.

Cardiol Young. 2018 Oct;28(10):1116-1121. doi: 10.1017/S1047951118001063. Epub 2018 Jul 11.

PMID:
29991378
3.

Stent unzipping using an ultra-high-pressure balloon: in vitro and animal experiments.

Fujimoto K, Fujii T, Hata Y, Tarui S, Miyahara Y, Ishino K, Tomita H.

Heart Vessels. 2018 Mar;33(3):239-245. doi: 10.1007/s00380-017-1060-x. Epub 2017 Oct 14.

PMID:
29032492
4.

[Delayed Diagnosis of Aortic Dissection Following Thrombolytic Therapy in a Patient with Acute Ischemic Stroke;Report of a Case].

Miyamoto Y, Masuda Z, Kotani Y, Tarui S, Kuroko Y, Fujii Y, Ozawa S, Sano S.

Kyobu Geka. 2016 Nov;69(12):1037-1040. Review. Japanese.

PMID:
27821831
5.

Novel Model of Pulmonary Artery Banding Leading to Right Heart Failure in Rats.

Hirata M, Ousaka D, Arai S, Okuyama M, Tarui S, Kobayashi J, Kasahara S, Sano S.

Biomed Res Int. 2015;2015:753210. doi: 10.1155/2015/753210. Epub 2015 Oct 4.

6.

Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.

Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, Oh H.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1198-1207, 1208.e1-2. doi: 10.1016/j.jtcvs.2015.06.076. Epub 2015 Jul 8.

7.

Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.

Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, Okuyama M, Kobayashi J, Baba K, Arai S, Kawabata T, Yoshizumi K, Tateishi A, Kuroko Y, Iwasaki T, Sato S, Kasahara S, Sano S, Oh H.

Circ Res. 2015 Feb 13;116(4):653-64. doi: 10.1161/CIRCRESAHA.116.304671. Epub 2014 Nov 17.

PMID:
25403163
8.

Stem cell therapies in patients with single ventricle physiology.

Tarui S, Sano S, Oh H.

Methodist Debakey Cardiovasc J. 2014 Apr-Jun;10(2):77-81. Review.

9.

Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome.

Kobayashi J, Yoshida M, Tarui S, Hirata M, Nagai Y, Kasahara S, Naruse K, Ito H, Sano S, Oh H.

PLoS One. 2014 Jul 22;9(7):e102796. doi: 10.1371/journal.pone.0102796. eCollection 2014.

10.

[Advances in studies on clinical medicine: a round-table discussion].

Nakao K, Imura H, Tarui S, Matsuzawa Y.

Nihon Rinsho. 2010 Apr;68(4):737-44. Japanese. No abstract available.

PMID:
20422789
11.

Successful combined treatment of primary cardiac malignant lymphoma with urgent cardiac operation and chemotherapy.

Fujita Y, Ikebuchi M, Tarui S, Irie H.

Circ J. 2009 May;73(5):967-9. Epub 2008 Dec 16.

12.

High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis.

Hirano H, Kurata A, Onishi Y, Sakurai A, Saito H, Nakagawa H, Nagakura M, Tarui S, Kanamori Y, Kitajima M, Ishikawa T.

Mol Pharm. 2006 May-Jun;3(3):252-65.

PMID:
16749857
13.

A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions.

Saito H, Hirano H, Nakagawa H, Fukami T, Oosumi K, Murakami K, Kimura H, Kouchi T, Konomi M, Tao E, Tsujikawa N, Tarui S, Nagakura M, Osumi M, Ishikawa T.

J Pharmacol Exp Ther. 2006 Jun;317(3):1114-24. Epub 2006 Feb 17.

PMID:
16489126
14.

Does ABCG2 need a heterodimer partner? Expression and functional evaluation of ABCG2 (Arg 482)*.

Yoshikawa M, Kasamatsu S, Yasunaga M, Wang G, Ikegami Y, Yoshida H, Tarui S, Yabuuchi H, Ishikawa T.

Drug Metab Pharmacokinet. 2002;17(2):130-5.

15.

Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses.

Ishikawa T, Hirano H, Onishi Y, Sakurai A, Tarui S.

Drug Metab Pharmacokinet. 2004 Feb;19(1):1-14. Review.

16.

Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).

Ishikawa T, Onishi Y, Hirano H, Oosumi K, Nagakura M, Tarui S.

Biol Pharm Bull. 2004 Jul;27(7):939-48. Review.

17.

[Idiopathic retroperitoneal fibrosis and hyperuricemia].

Mineo I, Nakagawa C, Tarui S.

Nihon Rinsho. 2003 Jan;61 Suppl 1:328-32. Review. Japanese. No abstract available.

PMID:
12629741
18.

[Biochemical aspects on plasma glucose in vertebrates--with reference to trehalose in insects].

Tarui S.

Nihon Rinsho. 2002 Jul;60 Suppl 7:94-100. Review. Japanese. No abstract available.

PMID:
12238136
20.

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.

Nakamura T, Funahashi T, Yamashita S, Nishida M, Nishida Y, Takahashi M, Hotta K, Kuriyama H, Kihara S, Ohuchi N, Nishimura T, Kishino BI, Ishikawa K, Kawamoto T, Tokunaga K, Nakagawa C, Mineo I, Watanabe F, Tarui S, Matsuzawa Y.

Diabetes Res Clin Pract. 2001 Dec;54(3):181-90.

PMID:
11689273
21.

Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys.

Ohmura T, Chachin M, Tarui S, Nagakura A, Igarashi T, Ikeda H, Ikegami K, Kitagawa H, Uchida S.

Eur J Pharmacol. 1999 Aug 6;378(2):169-75.

PMID:
10478629
22.

[Type VII glycogen storage disease].

Nakajima H, Hamaguchi T, Yamasaki T, Noguchi T, Tarui S.

Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):51-5. Review. Japanese. No abstract available.

PMID:
9589987
23.

[Carbohydrates: perspective].

Tarui S.

Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):7-10. Review. Japanese. No abstract available.

PMID:
9589974
24.

Two decades of annual medical examinations in Japanese obese children: do obese children grow into obese adults?

Kotani K, Nishida M, Yamashita S, Funahashi T, Fujioka S, Tokunaga K, Ishikawa K, Tarui S, Matsuzawa Y.

Int J Obes Relat Metab Disord. 1997 Oct;21(10):912-21.

PMID:
9347410
25.

Elevated serum lipoprotein (a) levels associated with ulcerative colitis in a young Japanese patient.

Kawabata S, Katagiri S, Negoro H, Nogami A, Yabuuchi I, Gomi M, Arima R, Tarui S.

Intern Med. 1997 Jun;36(6):389-91.

26.

[Carbohydrates and the human being].

Tarui S.

Nihon Rinsho. 1997 Oct;55 Suppl:11-6. Review. Japanese. No abstract available.

PMID:
9392086
27.

[Clinical effects of beni-koji in mild essential hypertension--a multi-center double-blind comparison with placebo].

Kushiro T, Hashida J, Kawamura H, Mitsubayashi H, Saito T, Suzuki Y, Takahashi N, Ishii T, Kimura T, Tsuji K, Tanabe N, Asano K, Abe S, Tarui S.

Nihon Jinzo Gakkai Shi. 1996 Dec;38(12):625-33. Japanese.

PMID:
9014483
28.

[The pathogenesis of NIDDM: genetic defects and environmental factors].

Nakagawa C, Mineo I, Tarui S.

Nihon Rinsho. 1996 Oct;54(10):2649-56. Review. Japanese. No abstract available.

PMID:
8914423
29.

Novel missense mutation (W686C) of the phosphofructokinase-M gene in a Japanese patient with a mild form of glycogenosis VII.

Hamaguchi T, Nakajima H, Noguchi T, Nakagawa C, Kuwajima M, Kono N, Tarui S, Matsuzawa Y.

Hum Mutat. 1996;8(3):273-5. No abstract available.

PMID:
8889589
30.

Abnormal evoked potentials of Kearns-Sayre syndrome.

Nakamura Y, Takahashi M, Kitaguchi M, Yorifuji S, Nishikawa Y, Imaoka H, Tarui S.

Electromyogr Clin Neurophysiol. 1995 Oct;35(6):365-70.

PMID:
8785934
31.

Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VII.

Ono A, Kuwajima M, Kono N, Mineo I, Nakagawa C, Tarui S, Matsuzawa Y.

Neurology. 1995 Jan;45(1):161-4.

PMID:
7824108
32.

Myogenic hyperuricemia: what can we learn from metabolic myopathies?

Mineo I, Tarui S.

Muscle Nerve Suppl. 1995;3:S75-81. Review.

PMID:
7603532
33.

A new variant case of muscle phosphofructokinase deficiency, coexisting with gastric ulcer, gouty arthritis, and increased hemolysis.

Nakagawa C, Mineo I, Kaido M, Fujimura H, Shimizu T, Hamaguchi T, Nakajima H, Tarui S.

Muscle Nerve Suppl. 1995;3:S39-44.

PMID:
7603526
34.

Phosphofructokinase deficiency: recent advances in molecular biology.

Nakajima H, Hamaguchi T, Yamasaki T, Tarui S.

Muscle Nerve Suppl. 1995;3:S28-34. Review.

PMID:
7603524
35.
36.

Impaired ketogenesis in patients with adult-type citrullinemia.

Inui Y, Kuwajima M, Kawata S, Fukuda K, Maeda Y, Igura T, Kono N, Tarui S, Matsuzawa Y.

Gastroenterology. 1994 Oct;107(4):1154-61.

PMID:
7926463
37.

The NOD mouse.

Hanafusa T, Miyagawa J, Nakajima H, Tomita K, Kuwajima M, Matsuzawa Y, Tarui S.

Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S307-11. Review.

PMID:
7859625
38.

A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal RNA splicing.

Hamaguchi T, Nakajima H, Noguchi T, Ono A, Kono N, Tarui S, Kuwajima M, Matsuzawa Y.

Biochem Biophys Res Commun. 1994 Jul 15;202(1):444-9.

PMID:
7518679
39.

Sexual dimorphism of age-related changes in whole-body fat distribution in the obese.

Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, Shimomura I, Tarui S, Matsuzawa Y.

Int J Obes Relat Metab Disord. 1994 Apr;18(4):207-2.

PMID:
8044194
40.

Serum pancreatic phospholipase A2 and prophospholipase A2 in acute pancreatitis and after endoscopic retrograde pancreatography.

Yamamoto K, Shinomura Y, Tojo H, Okamoto M, Tarui S.

Gastroenterol Jpn. 1993 Oct;28(5):679-86.

PMID:
8224619
41.

[Visceral fat obesity].

Tarui S.

Nihon Naika Gakkai Zasshi. 1993 Sep 10;82(9):1547-53. Japanese. No abstract available.

PMID:
8245658
42.

Overexpression of HLA class I antigen reduces insulin secretion in pancreatic beta cells (RINM5F): evidence for a non-immune mechanism.

Yamagata K, Hanafusa T, Nakajima H, Sato T, Noguchi T, Tomita K, Tsuji K, Kono N, Tanaka T, Tarui S, et al.

Res Commun Chem Pathol Pharmacol. 1993 Sep;81(3):299-308.

PMID:
8235064
43.
44.

Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles.

Nomura Y, Matsuda Y, Yabuuchi I, Nishioka M, Tarui S.

Radiology. 1993 May;187(2):353-6.

PMID:
8386389
45.

Laparoscopic findings in asymptomatic primary sclerosing cholangitis.

Kakimoto H, Kawata S, Imai Y, Kiyonaga G, Tarui S.

Endoscopy. 1993 May;25(4):313. No abstract available.

PMID:
8330560
46.
47.
48.

Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation.

Jinnai K, Kono N, Yamamoto Y, Kanda F, Ohno S, Tsutsumi M, Yamada Y, Kawachi M, Tarui S, Fujita T.

Eur Neurol. 1993;33(3):204-7.

PMID:
8467838
49.

Aromatase activity in human hepatocellular carcinoma. Relationship with the degree of histologic differentiation.

Yabuuchi I, Kawata S, Tamura S, Ito N, Matsuda Y, Nishioka M, Moriwaki K, Matsuzawa Y, Tarui S.

Cancer. 1993 Jan 1;71(1):56-61.

PMID:
8380122
50.

Nephrosialidosis: ultrastructural and lectin histochemical study.

Toyooka K, Fujimura H, Yoshikawa H, Taniike M, Inui K, Yorifuji S, Tarui S, Okada S, Yanagihara T.

Acta Neuropathol. 1993;86(2):198-205.

PMID:
8213076

Supplemental Content

Support Center